With these kind of results, they may not need to raise via shareholders. For any Ausie biotech to progress, they need US partners. Their existing US partner should already have opened some doors. With R&D funds coming, they may have a large enough window to do a deal with someone.
Ann: Breakthrough Results a Major Step Towards Commercialisation, page-14
Add BDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.015(13.0%) |
Mkt cap ! $46.44M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 13.0¢ | 11.5¢ | $134.7K | 1.159M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 783923 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 6917 | 1 |
View Market Depth
| Last trade - 15.40pm 29/07/2024 (20 minute delay) ? |
| BDX (ASX) Chart |